Flex Vascular
Flex Vascular develops and markets endovascular devices for stenoses of AV fistulas and grafts and peripheral vascular disease.
- 5
- Company
- Plymouth, MN, USUnited States
Flex Vascular develops and markets endovascular devices for stenoses of AV fistulas and grafts and peripheral vascular disease.
Flex Vascular, the operating name of VentureMed Group, Inc., develops and markets endovascular devices that address unmet needs in treating stenoses of AV fistulas and grafts and peripheral vascular disease, led by the FLEX Vessel Prep System and its KEMIC micro-incision technology that avoids balloon-based static pressure.
The company's flagship product is the FDA 510(k)-cleared and CE Mark-approved FLEX Vessel Prep System. Unlike traditional balloon-based approaches that apply static pressure, its KEMIC technology leverages controlled motion and dynamic vessel apposition to create long, precise micro-incisions. The company brings its vessel preparation technology to clinicians and patients.
Efemoral Medical
Access Vascular
Voyager Biomedical
Vascular Dynamics
Cagent Vascular
cagentvascular.com
Alucent Biomedical
alucentmedical.com
Bluegrass Vascular Technologies
VenoStent
venostent.com
Avenu Medical
avenumedical.com
Saphena Medical
ATTWILL Vascular Technologies
Micro Medical Solutions
Advanced Catheter Therapies
acatheter.com
Venarum Medical
Medical 21
medical21.com
Artventive Medical Group
Amplitude Vascular Systems
avspulse.com
Venova Medical
venovamed.com
Venock
venock.com
Vascular Therapies
vasculartx.com
Companies similar to Flex Vascular include Efemoral Medical, Access Vascular, Voyager Biomedical and Vascular Dynamics.
Flex Vascular was founded in 2000.
Flex Vascular's headquarters is located in Plymouth, MN, US.
Flex Vascular's most recent funding round was for $28M (USD) in October 2025.
As of Oct 29, 2025, Flex Vascular has disclosed funding of $56M (USD).
Flex Vascular has 5 employees as of Feb 4, 2024.